Racial, ethnic disparities explored in subjective cognitive decline
Jul 08, 2021
More Black and Hispanic adults than white adults report subjective cognitive decline at age 45 to 54 years.
A very troubling $56 billion question
By
John O'Connor
Jul 08, 2021
Considering some of the alternatives, I’m far from convinced that bankrupting Medicare for the sake of Aduhelm would be money well spent.
Senior living community trains first responders to ‘take it down a notch’ through dementia education
By
Kimberly Bonvissuto
Jul 07, 2021
After witnessing a troubled interaction between a young police officer and a man with dementia, one senior living community offered to train first responders on communication techniques to increase successful...
Changes in movement may indicate preclinical Alzheimer’s disease
Jul 02, 2021
Changes in daytime fractal motor activity regulation may occur in women before cognitive symptoms of Alzheimer’s disease.
House committees to investigate new Alzheimer’s disease drug approval
Jul 01, 2021
The FDA approved aducanumab earlier this month, despite advisory committee’s conclusion that there was not enough evidence to support its effectiveness.
COVID-19 falls from America’s No. 1 killer to No. 7 by June
Jul 01, 2021
COVID-19 deaths have fallen sharply as vaccination rates have surged in recent months.
Prediction model for brain age may help detect cognitive decline
Jul 01, 2021
Greater differences between predicted age based on brain MRI and actual age were seen in those with amnestic mild cognitive impairment versus healthy controls.
More news for Monday, June 28
Jun 28, 2021
DA reverses plans to seek death penalty for alleged senior living serial killer … FDA grants breakthrough therapy designation to donanemab and lecanemab for Alzheimer’s … Vapors from alcohol-based...
Lilly to seek FDA approval for new drug for Alzheimer’s disease
Jun 25, 2021
Donanemab already has received a ‘breakthrough therapy’ designation from the FDA.
Florida increases state funding for Alzheimer’s disease to $51 million
By
Kimberly Bonvissuto
Jun 23, 2021
Florida is increasing its funding for Alzheimer’s and dementia funding by more than $12 million, bringing the state’s total commitment to more than $51 million for the 2021-2022 fiscal year.